| Reference |
|
117
Baker EJ, Ichiki AT, Day NE, Andrews RB, Bamberger EG, Lozzio CB.
Simultaneous flow cytometric measurement of K-562 megakaryocytic differentiation and CD56+ large granular lymphocyte cytotoxicity
J Immunol Methods
2001
253(1-2):37-44
PubMed ID: 11384667
|
|
98
Baker EJ, Ichiki AT, Hodge JW, Sugantharaj D, Bamberger EG, Lozzio CB.
PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro
Leuk Res
2000
24(12):1049-57.
PubMed ID: 11077119
DOI: 10.1016/s0145-2126(00)00082-5
|
|
97
Ichiki AT, Langenberg M, Baker EJ, Hodge JW, Bamberger EG, Gerard DA, Lozzio CB.
Differential regulation of interleukin-1alpha and interleukin-1beta in K-562 cells
J Interferon Cytokine Res
1998
18(12):1045-50
PubMed ID: 9877448
DOI: 10.1089/jir.1998.18.1045
|
|
101
Wust CJ, Hodge JW, Ichiki AT, Lozzio CB.
Cell death in the human leukemia cell line, K-562, induced by antiserum and monoclonal antibodies
Leuk Res
1991
15(6):497-506
PubMed ID: 1713636
DOI: 10.1016/0145-2126(91)90061-w
|
|
103
Ichiki AT, Sugantharaj DG, Hudson CS, Gerard DA, Barnhill MA, Bamberger EG, Wust CJ, Fuhr JE, Lozzio CB.
Lowered susceptibility of K-562 cells treated with gamma interferon in serum-free medium to natural killer cell-mediated cytolysis
Nat Immun Cell Growth Regul
1988
7(5-6):297-304
PubMed ID: 3146698
|
|
106
Walter H, Krob EJ, Al-Romaihi FA, Johnson D, Lozzio CB.
Detection of surface differences between closely related cell populations by partitioning. Cultured K-562 cell sublines
Cell Biophys
1988
13(3):173-87
PubMed ID: 2465826
DOI: 10.1007/BF02918374
|
|
5042
Haruta Y, Seon BK.
Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
Proc Natl Acad Sci U S A
1986
83(20):7898-902
PubMed ID: 3464004
DOI: 10.1073/pnas.83.20.7898
|
|
95
Ichiki AT, Bamberger EG, Wust CJ, Lozzio CB.
Diversity of cell surface hematopoietic antigens on K-562 sublines identified with monoclonal antibodies
Leuk Res
1986
10(5):565-74
PubMed ID: 2940421
DOI: 10.1016/0145-2126(86)90092-5
|
|
96
Ichiki AT, Wust CJ, Lozzio CB.
Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562
Clin Exp Immunol
1985
59(1):64-8
PubMed ID: 3971599
|
|
116
Rowley PT, Ohlsson-Wilhelm BM, Wisniewski L, Lozzio CB, Lozzio BB.
K562 human leukemia cell passages differ in embryonic globin gene expression
Leuk Res
1984
8(1):45-54
PubMed ID: 6199625
|
|
100
Lozzio BB, Machado EA, Mitchell J, Lozzio CB, Wust CJ, Golde DW.
Proliferation of human malignant hematopoietic cells in immunodeficient mice: suppression by antibody to pluripotent K-562 leukemia cells involves direct cytolysis and effector cells
Blood
1983
61(6):1045-53
PubMed ID: 6132631
|
|
94
Wust CJ, Green M, Lozzio CB, Lozzio BB.
Antibody-dependent cytolysis of the human leukemia cell line K-562 in the absence of effector cells or complement
Blood
1982
59(1):133-40
PubMed ID: 7053760
|
|
102
Ichiki AT, Lozzio BB, Wust CJ, Lozzio CB.
Relationship between the Fc receptor for IgG and the specific associated antigen of the pluripotential leukaemia cell line, K-562
Clin Exp Immunol
1982
50(2):360-5
PubMed ID: 6185259
|
|
105
Machado EA, Gerard DA, Mitchell JR, Lozzio BB, Lozzio CB.
Arrest and extravasation of neoplastic cells. An electron microscopy study of serial sections at sequential stages
Virchows Arch A Pathol Anat Histol
1982
396(1):73-89
PubMed ID: 7123846
DOI: 10.1007/BF00428501
|
|
107
Lozzio CB, Lozzio BB, Wust CJ, Bamberger EG, Golde DW, Minowada J.
Antibody lysis of human hematopoietic cells in the absence of complement and effector cells
Exp Hematol
1982
10(8):698-707
PubMed ID: 6183138
|
|
115
Perez RL, Mitchell JR, Lozzio BB.
Relevance of lipids to heterotransplantation of human malignancies
Oncology
1982
39(3):179-84
PubMed ID: 7043353
DOI: 10.1159/000225632
|
|
93
Fuhr JE, Bamberger EG, Lozzio CB, Lozzio BB.
Induction of hemoglobin synthesis in original K 562 cell line
Blood Cells
1981
7(2):389-99
PubMed ID: 6170369
|
|
108
Latif ZA, Lozzio BB, Wust CJ, Krauss S, Aggio MC, Lozzio CB.
Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice
Cancer
1980
45(6):1326-33
PubMed ID: 6928397
DOI: 10.1002/1097-0142(19800315)45:6<1326::aid-cncr2820450610>3.0.co;2-y
|
|
113
Lair SV, Lozzio BB.
Thymocyte reconstitution of athymic and athymic-asplenic mice: graft rejection and antibody synthesis
Exp Cell Biol
1980
48(6):439-44
PubMed ID: 6967835
DOI: 10.1159/000163010
|
|
4603
Lozzio BB, Lozzio CB.
Properties and usefulness of the original K-562 human myelogenous leukemia cell line.
Leuk Res
1979
3(6):363-70
PubMed ID: 95026
DOI: 10.1016/0145-2126(79)90033-x
|
|
969
Rutherford TR, Clegg JB, Weatherall DJ.
K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin.
Nature
1979
280(5718):164-5
PubMed ID: 95354
DOI: 10.1038/280164a0
|
|
970
Andersson LC, Jokinen M, Gahmberg CG.
Induction of erythroid differentiation in the human leukaemia cell line K562.
Nature
1979
278(5702):364-5
PubMed ID: 570644
DOI: 10.1038/278364a0
|
|
89
Lozzio BB, Machado EA, Lair SV, Lozzio CB.
Reproducible metastatic growth of K-562 human myelogenous leukemia cells in nude mice
J Natl Cancer Inst
1979
63(2):295-9
PubMed ID: 287825
|
|
112
Lozzio CB, Lozzio BB, Wust CJ, Kim J.
Correlation of leukemia-associated antigens and Ph1 chromosome in fibroblastlike cells derived from bone marrow
Blood
1978
52(4):673-80
PubMed ID: 99197
|
|
114
Lozzio BB, Lozzio CB, Bamberger EG.
Cytotoxicity of a factor from normal and abnormal human spleens for allogenic leukemia cells
Am J Hematol
1978
4(1):57-65
PubMed ID: 655158
DOI: 10.1002/ajh.2830040108
|
|
99
Collins JL, Wust CJ, Lozzio BB, Lozzio CB.
Characterization of an antigen from the myelogenous leukemia cell line K-562
J Natl Cancer Inst
1977
59(6):1667-74
PubMed ID: 72824
DOI: 10.1093/jnci/59.6.1667
|
|
109
Lozzio BB, Lozzio CB, Krauss S, Wust CJ, Girardi A.
Leukemia-associated antigens detected by a nonhuman primate antiserum to a Ph1+ myeologenous leukemia cell line
Blood
1977
50(1):115-24
PubMed ID: 68791
|
|
111
Lozzio BB, Machado EA, Lair SA, Lozzio CB.
Suppression of human myelosarcoma growth in athymic mice by a primate antiserum
Cancer Treat Rep
1977
61(9):1679-84
PubMed ID: 271518
|
|
88
Lozzio CB, Lozzio BB, Yang WK, Ichiki AT, Bamberger EG.
Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562
Cancer Res
1976
36(12):4657-62
PubMed ID: 63324
|
|
104
Lozzio BB, Lozzi CB, Machado E.
Human myelogenous (Ph+) leukemia cell line: transplantation into athymic mice
J Natl Cancer Inst
1976
56(3):627-9
PubMed ID: 1062625
DOI: 10.1093/jnci/56.3.627
|
|
110
Lozzio BB, Machado EA, Lozzio CB, Lair S.
Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells
J Exp Med
1976
143(1):225-31
PubMed ID: 53268
DOI: 10.1084/jem.143.1.225
|
|
4602
Lozzio CB, Lozzio BB.
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.
Blood
1975
45(3):321-34
PubMed ID: 163658
|
| User's Publication |
|
21671
Mi D, Yanatori I, Zheng H, Kong Y, Hirayama T, Toyokuni S.
Association of poly(rC)-binding protein-2 with sideroflexin-3 through TOM20 as an iron entry pathway to mitochondria.
Free Radic Res
2024
1-40
PubMed ID: 38599240
DOI: 10.1080/10715762.2024.2340711
|
|
21717
Kasai F, Mizukoshi K, Nakamura Y.
Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature
Sci Rep
2024
14(1):9619
PubMed ID: 38671192
DOI: 10.1038/s41598-024-60271-8
|
|
18139
Hoshino N, Kanadome T, Takasugi T, Itoh M, Kaneko R, Inoue YU, Inoue T, Hirabayashi T, Watanabe M, Matsuda T, Nagai T, Tarusawa E, Yagi T.
Visualization of trans homophilic interaction of clustered protocadherin in neurons
Proc Natl Acad Sci U S A
2023
120(38):e2301003120
PubMed ID: 37695902
DOI: 10.1073/pnas.2301003120
|
|
21353
Kanadome T, Hoshino N, Nagai T, Yagi T, Matsuda T.
Visualization of trans-interactions of a protocadherin-α between processes originating from single neurons.
iScience
2023
26(7):107238
PubMed ID: 37534169
DOI: 10.1016/j.isci.2023.107238
|
|
20321
Izumi K, Shindo T, Ngo HT, Nakayama-Hosoya K, Akahane K, Tamai M, Nguyen TTT, Kawana-Tachikawa A, Inukai T, Takaori-Kondo A.
KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.
Immunohorizons
2021
5(8):687-702
PubMed ID: 34433624
DOI: 10.4049/immunohorizons.2100054
|
|
20440
Kanadome T, Hoshino N, Nagai T, Matsuda T, Yagi T.
Development of FRET-based indicators for visualizing homophilic trans interaction of a clustered protocadherin.
Sci Rep
2021
11(1):22237
PubMed ID: 34782670
DOI: 10.1038/s41598-021-01481-2
|
|
18206
Viriyaadhammaa N, Saiai A, Neimkhum W, Nirachonkul W, Chaiyana W, Chiampanichayakul S, Tima S, Usuki T, Duangmano S, Anuchapreeda S.
Cytotoxic and Antiproliferative Effects of Diarylheptanoids Isolated from Curcuma comosa Rhizomes on Leukaemic Cells
Molecules
2020
25(22):5476
PubMed ID: 33238470
DOI: 10.3390/molecules25225476
|
|
11912
Chen Z, Nishimura N, Okamoto T, Wada K, Naora K.
Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells.
Biomed Res Int
2019
PubMed ID: 31871929
DOI: 10.1155/2019/1269532
|
|
12489
Anuchapreeda S, Rungrojsakul M, Tima S, Chiampanichayakul S, Krig SR.
Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells
Cell Signal
2019
53:339-347
PubMed ID: 30395942
DOI: 10.1016/j.cellsig.2018.11.001
|
|
4269
Hirao T, Yamaguchi M, Kikuya M, Chibana H, Ito K, Aoki S.
Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells.
Cancer Sci.
2018
PubMed ID: 29121435
DOI: 10.1111/cas.13442
|
|
14533
Zhi Chen, Nobuhiro Nishimura, Takayuki Okamoto, Koichiro Wada, Kohji Naora
ABCB1-mediated multi-drug resistance in leukemic K562/ADR cells was reversed by Matrine, the main ingredient from Sophora alopecuroides
Proceedings for Annual Meeting of The Japanese Pharmacological Society
2018
WCP2018:PO3-7-14
DOI: 10.1254/jpssuppl.wcp2018.0_po3-7-14
|
|
13998
Nakai W, Yoshida T, Diez D, Miyatake Y, Nishibu T, Imawaka N, Naruse K, Sadamura Y, Hanayama R.
A novel affinity-based method for the isolation of highly purified extracellular vesicles
Sci Rep
2016
6:33935
PubMed ID: 27659060
DOI: 10.1038/srep33935
|
|
14001
Bologna-Molina R, Takeda Y, Kuga T, Chosa N, Kitagawa M, Takata T, Ishisaki A, Mikami T.
Expression of Wilms' tumor 1 (WT1) in ameloblastomas
J Oral Sci
2016
58(3):407-13
PubMed ID: 27665981
DOI: 10.2334/josnusd.15-0546
|
|
13885
Umsumarng S, Pitchakarn P, Sastraruji K, Yodkeeree S, Ung AT, Pyne SG, Limtrakul P.
Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function
Basic Clin Pharmacol Toxicol
2015
116(5):390-7
PubMed ID: 25265513
DOI: 10.1111/bcpt.12331
|
|
18179
Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, Iwakura Y, Taniguchi T.
Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses
Elife
2014
3:e04177
PubMed ID: 25149452
DOI: 10.7554/eLife.04177
|
|
13882
Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y.
Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein
Biochem Biophys Res Commun
2014
448(4):430-6
PubMed ID: 24796664
DOI: 10.1016/j.bbrc.2014.04.125
|
Back
Top
CELL BANK Website